Compounds represented by Formula (I):
1
or a pharmaceutically acceptable salt or N-oxide thereof, wherein R1 is
2
R2 is
3
and R3 is C
0-4
alkyl, are useful in the treatment of cancer.
A method of treatment of hyperproliferative disorders comprises administering an effective amount of a compound represented by Formula II:
or a pharmaceutically acceptable salt thereof.